Review of current therapeutic approaches for polycystic ovary syndrome
Abstract
Introduction. Polycystic ovary syndrome is a multifaceted endocrine disorder
affecting 5-15% of women of reproductive age. This review aims to explore
and synthesize current therapeutic strategies for managing polycystic ovary
syndrome, emphasizing lifestyle modifications, pharmacological treatments,
and emerging alternative therapies. A systematic literature search was
conducted, focusing on randomized controlled trials, metaanalyses, and
observational studies examining interventions that improve metabolic,
reproductive, and psychological outcomes in women with polycystic ovary
syndrome. Current Therapeutic Strategies. Lifestyle interventions, including
weight management and regular exercise, are fundamental in enhancing insulin
sensitivity and alleviating symptoms such as menstrual irregularities and
hirsutism. Pharmacological treatments, including hormonal contraceptives,
metformin, and anti-androgens, play a vital role in managing
hyperandrogenism and promoting fertility. Additionally, emerging therapies,
such as glucagon-like peptide-1 receptor agonists and herbal supplements,
show potential in addressing metabolic dysfunction. Nutritional
supplementation, particularly vitamin D, folic acid, and omega-3 fatty
acids, has demonstrated benefits in improving both metabolic and
reproductive outcomes. Complementary treatments, including acupuncture and
herbal medicine, also hold promise but require further validation through
robust clinical research. Conclusion. A…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.